Alnylam Pharmaceuticals ALNY Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 336%-11.5pp | 347.5%+6.2pp | 341.3%-5.3pp | 346.6%+2.6pp | |
| Operating margin | 9.5%+30.8pp | -21.2%+150pp | -171.7%+143pp | -314.9%+114pp | |
| Net margin | -11.1%+36.8pp | -47.9%+185pp | -232.7%+212pp | -444.4%+50.9pp | |
| Efficiency | |||||
| Asset turnover | 2.7×+0.4× | 2.3×+0.6× | 1.7×+0.6× | 1.1×+0.2× | |
| Liquidity | |||||
| Current ratio | 11.1×-0.6× | 11.7×-1.5× | 13.2×-1.8× | 15×-3.3× | |
| Leverage | |||||
| Debt-to-equity | 3.2×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $12.77+1,396% | -$0.99+88.3% | -$8.39-386% | $2.93-88.9% | |
| Valuation | |||||
| Market capitalization | $189.63B+64.6% | $115.22B+21.7% | $94.68B+4.6% | $90.51B+13.1% | |
| Price / sales | 64.9×+12.0× | 52.9×-14.0× | 66.8×-28.6× | 95.4×-17.8× | |
| Price / book | 573.2×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Alnylam Pharmaceuticals's profit margins?
- Alnylam Pharmaceuticals (ALNY) runs a 81.0% gross margin and a 17.5% operating margin, with a 11.7% net margin.
- Where do Alnylam Pharmaceuticals's ratios come from?
- Every ratio is computed from Alnylam Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
